Stephan Grupp discussing his work at the University of Pennsylvania VJHemOnc – Video Journal of Hematology & HemOnc 1:11 8 years ago 333 Скачать Далее
Cancer Immunotherapy Program: Video Tour The Children's Hospital of Philadelphia 6:52 6 years ago 16 600 Скачать Далее
CTL019 in pediatric and young adult relapsed/refractory acute lymphoblastic leukemia (ALL) patients VJHemOnc – Video Journal of Hematology & HemOnc 2:10 7 years ago 598 Скачать Далее
Real world experience of tisagenlecleucel for R/R ALL in the US VJHemOnc – Video Journal of Hematology & HemOnc 1:27 4 years ago 144 Скачать Далее
The moral dangers of non-lethal weapons | Stephen Coleman TED 17:33 12 years ago 52 085 Скачать Далее
CAR-T as a frontline standard of care in ALL? VJHemOnc – Video Journal of Hematology & HemOnc 0:51 4 years ago 44 Скачать Далее
The latest research in ALL cellular therapy VJHemOnc – Video Journal of Hematology & HemOnc 2:16 2 years ago 51 Скачать Далее
Real-world data on CAR-T therapy for B-ALL VJHemOnc – Video Journal of Hematology & HemOnc 1:25 3 years ago 183 Скачать Далее
Identifying relapse in B-ALL patients treated with tisagenlecleucel using MRD VJHemOnc – Video Journal of Hematology & HemOnc 2:06 5 years ago 456 Скачать Далее
MRD: making clinical decisions in ALL VJHemOnc – Video Journal of Hematology & HemOnc 2:16 6 years ago 323 Скачать Далее
The CAR T Revolution: Opportunities and Challenges Yale Cancer Center 48:10 5 years ago 179 Скачать Далее
ASH 2017 highlights: Cell therapy approaches in ALL VJHemOnc – Video Journal of Hematology & HemOnc 1:36 6 years ago 142 Скачать Далее
Comparing CAR T-cell toxicity in ALL and lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 2:14 6 years ago 224 Скачать Далее
The future of treating pediatric ALL with CAR-T VJHemOnc – Video Journal of Hematology & HemOnc 1:21 2 years ago 44 Скачать Далее
The importance of common language for CAR-T VJHemOnc – Video Journal of Hematology & HemOnc 0:57 3 years ago 23 Скачать Далее
